Distinguished in Stroke

Laura Mechtouff

Hospices Civils De Lyon
Bron, FR 
Distinguished in Stroke
Hospices Civils De Lyon
Bron, FR 
OverviewLocationsClinical Research

Overview

Laura Mechtouff practices in Bron, France. Ms. Mechtouff is rated as a Distinguished expert by MediFind in the treatment of Stroke. Her top areas of expertise are Stroke, Carotid Artery Disease, Transient Ischemic Attack (TIA), Thrombectomy, and Patent Foramen Ovale Repair.

Her clinical research consists of co-authoring 103 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 80 articles and participated in 2 clinical trials in the study of Stroke.

Gender
Female

Locations

Hospices Civils de Lyon
Bron, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Assessment of Symptomatic and Asymptomatic Carotid Plaques Using Hybrid Imaging 18F-sodium Fluoride PET/MR
Assessment of Symptomatic and Asymptomatic Carotid Plaques Using Hybrid Imaging 18F-sodium Fluoride PET/MR
Enrollment Status: Completed
Publish Date: September 04, 2025
Intervention Type: Drug
Study Phase: Not Applicable
A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
Enrollment Status: Completed
Publish Date: January 24, 2024
Intervention Type: Drug
Study Drugs: Alteplase, Acetylsalicylic acid
Study Phase: Phase 3
Impact of a Pluriprofessional Intervention to Improve Medication Adherence (Secondary Preventive Medication) in Patients After Ischemic Stroke (ADMED-AVC)
Impact of a Pluriprofessional Intervention to Improve Medication Adherence (Secondary Preventive Medication) in Patients After Ischemic Stroke (ADMED-AVC)
Enrollment Status: Unknown
Publish Date: December 20, 2019
Intervention Type: Behavioral
Study Phase: Not Applicable
View 2 Less Clinical Trials

103 Total Publications

Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial.
Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial.
Journal: The Lancet. Neurology
Published: May 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mechtouff's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile